Location History:
- Macclesfield, GB (2014)
- Cheshire, GB (2015 - 2018)
Company Filing History:
Years Active: 2014-2018
Title: Thomas Langer: Innovator in Pharmaceutical Compounds
Introduction
Thomas Langer is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate chemokine receptor activity. With a total of 3 patents to his name, Langer's work is instrumental in advancing medical treatments.
Latest Patents
Langer's latest patents include a compound that is either a pyrimidine sulfonamide or a pharmaceutically acceptable salt thereof. This compound is characterized by its crystalline forms and processes for obtaining it. Additionally, it encompasses pharmaceutical intermediates used in its manufacture and pharmaceutical compositions containing the compound. The compound is particularly useful in treating diseases or conditions where modulation of chemokine receptor activity is beneficial.
Career Highlights
Langer is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca focuses on innovative solutions in drug development, contributing to the company's mission of improving patient outcomes through science.
Collaborations
Some of Langer's notable coworkers include Stephen Connolly and Mark Richard Ebden. Their collaborative efforts in research and development have further enhanced the impact of their work in the pharmaceutical industry.
Conclusion
Thomas Langer's contributions to pharmaceutical innovations highlight his role as a key inventor in the field. His patents reflect a commitment to advancing medical science and improving treatment options for various conditions.